OXIPURITY® Powder

OXIPURITY® Powder
Product Description

Our Polyethylene Glycols (PEGs) in Powder provide excellent flowability and uniform particle size, supporting efficient manufacturing oftablets and hard capsule formulations. Produced in compliance with GMP standards and meeting USP and European Pharmacopoeia (EP) requirements, they help enhance formulation homogeneity, API dispersion, and overall process consistency.

Indovinya

  • Country/Region:
    Brazil
  • On CPHI since:
    2026
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator
Specifications
  • Details
    USP & EP
  • Model
    Macrogol

Indovinya

  • Country/Region:
    Brazil
  • On CPHI since:
    2026
  • Employees:
    1000 - 4999
Company types
Manufacturer/Innovator

More Products from Indovinya (2)

  • EMCAPlus® Line

    Product EMCAPlus® Line

    The EMCAplus® Line offers high-quality mineral oils and petrolatum solutions for pharmaceutical formulations. Acting as effective carriers, emollients, and protective agents, EMCAplus® products support active ingredient delivery, moisturization, skin protection, and formulation stability across a wide rang...
  • OXIPURITY® Line

    Product OXIPURITY® Line

    The OXIPURITY® Line offers a comprehensive range of excipient solutions for Pharmaceutical applications. Including Polyethylene Glycols (PEGs), Polysorbates, Glycerin, and Propylene Glycol, the portfolio is designed to support solubilization, stabilization, emulsification, moisture retention, and overall f...

Indovinya resources (2)

  • Video Pharmaceutical Research and Development Center

    At Indovinya, innovation drives everything we do. Through our state-of-the-art R&D Center, we support our partners and customers in finding the right excipient for their formulations across the pharmaceutical industry.

    Together, we are shaping the future by advancing well-being and health.
    Watch the video to see how we deliver value in the pharmaceutical segment (human and animal)!
  • Video Applied Formulation Science: the strategic role of excipients

    In pharmaceutical development, performance goes far beyond the active pharmaceutical ingredient (API). Stability, bioavailability, scalability, and patient experience are all shaped by formulation decisions — and excipients play a strategic role in making innovation reliable. 

     In this episode of the Indovinya Expert Series, Hemyle Chaves, Pharma Researcher at Indovinya, shares how applied formulation science, excipient chemistry, and data‑driven insights support robust, compliant, and scalable pharmaceutical formulations. 


    From topical applications to predictive models and formulation flexibility, discover how the right excipient selection helps reduce risk, increase robustness, and ensure consistent performance from lab to industry.